Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial Tasuku Harada, M.D., Saori Kosaka, M.D., Joerg Elliesen, M.D., Masanobu Yasuda, Makoto Ito, Mikio Momoeda, M.D. Fertility and Sterility Volume 108, Issue 5, Pages 798-805 (November 2017) DOI: 10.1016/j.fertnstert.2017.07.1165 Copyright © 2017 The Authors Terms and Conditions
Figure 1 Patient flow during the double-blind treatment phase (week 24) and the open-label extension phase (week 52) of the study (full analysis set [FAS]). Fertility and Sterility 2017 108, 798-805DOI: (10.1016/j.fertnstert.2017.07.1165) Copyright © 2017 The Authors Terms and Conditions
Figure 2 (A) Reduction from baseline to week 24 in pain measures associated with endometriosis; (B) gynecologic endpoints. Fertility and Sterility 2017 108, 798-805DOI: (10.1016/j.fertnstert.2017.07.1165) Copyright © 2017 The Authors Terms and Conditions